Prof. Yumei Zhang 张玉梅
Chief Physician, Professor
Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gastrointestinal tumors, primary liver cancer, nasopharyngeal cancer, lung cancer, and breast cancer, with a focus on biological therapy for malignant tumors.
Dr. Zhang is a Professor and Chief Physician with a Master of Medicine. Since graduating from Guangxi Medical University in 2000, Dr. Zhang has worked in clinical oncology, research, and teaching. Dr. Zhang supervises master's students, leads two natural science foundation projects, participates in six research projects, and has published over 20 academic papers.
Professional roles
- Member, Precision Medicine and Tumor MDT Professional Committee, China Research Hospital Association
- Member, Chemotherapy Professional Committee, Guangxi Anti-Cancer Association
- Member, Rehabilitation and Palliative Care Professional Committee, Guangxi Anti-Cancer Association
- Member, Biological Therapy Professional Committee, Guangxi Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Yumei). Papers usually list the name as Yumei Zhang or Zhang Y.
Selected publications
16 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Oncol, 2026 (first author): Prognostic genes in hepatocellular carcinoma and their function: an analysis integrating high-throughput-based spatial transcriptomics and single-cell RNA-sequencing. PubMed 42169880
- Eur J Med Res, 2025 (first author): Hyaluronan-mediated motility receptor regulating the Wnt/β-catenin signaling resulting in hepatocellular carcinoma by inhibiting the phosphorylation activity of GSK-3β. PubMed 41168860
- Discov Oncol, 2025 (senior author): RNA m(6)A methylation patterns in hepatocellular carcinoma and their association with characteristics of the tumor microenvironment and prognosis. PubMed 40515874
- Front Immunol, 2021 (senior author): Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. PubMed 34925311
- BMC Gastroenterol, 2020 (senior author): Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature. PubMed 32375670
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion